tradingkey.logo

Papa Medical Ord Shs Class A (Proposed)

PAPA
0.0000.00%
收盘 01/23, 16:00美东报价延迟15分钟
--总市值
--市盈率 TTM

Papa Medical Ord Shs Class A (Proposed)

0.0000.00%

关于 Papa Medical Ord Shs Class A (Proposed) 公司

Papa Medical Inc. is an end-to-end cannabis dosing solution provider in the United States that sells nebulizer. The Company is engaged in the key activities in the cannabis and consuming e-vapors industry, from the research and development, formulation design, e-liquid production, e-liquid filling to e-liquid co-packing services. It has approximately 50 series of e-vapors. Its products include iPrefer 8-D, iPrefer 20, iPrefer 30, iPrefer 36-A, AIR INS U1 and AIR INS L1. It provides comprehensive solutions to companies in the cannabis and tobacco industries. The Company's cannabis e-vapors are sold directly by it, with most of its sales being to other cannabis dosing brands who purchase the product from it on an original design manufacturer basis and sells the products under their brand name, although its Cannapresso brand name and/or sub-brand names of VLPUL and HOOLOO may be included on the product. Its cannabis E-vapors primarily use various technologies, such as AiMesh and feelmixX.

Papa Medical Ord Shs Class A (Proposed)简介

公司代码PAPA
公司名称Papa Medical Inc
上市日期- -
CEOHua (Jian)
员工数量29
证券类型Ordinary Share
年结日- -
公司地址202 North California Ave
城市CITY OF INDUSTRY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91744
电话16268550800
网址https://www.cannapresso.com
公司代码PAPA
上市日期- -
CEOHua (Jian)

Papa Medical Ord Shs Class A (Proposed)公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jian Hua
Dr. Jian Hua
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lina Song
Ms. Lina Song
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Ms. Fei Xu
Ms. Fei Xu
General Manager, Director
General Manager, Director
--
--
Mr. Joel Adalberto Gallo
Mr. Joel Adalberto Gallo
Independent Director
Independent Director
--
--
Mr. Douglas Bruce Noyes
Mr. Douglas Bruce Noyes
Independent Director
Independent Director
--
--
Dr. James Jiayuan Tong
Dr. James Jiayuan Tong
Independent Director
Independent Director
--
--
Ms. Hua Yao
Ms. Hua Yao
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Weilin Ye
Mr. Weilin Ye
Deputy Chief Financial Officer
Deputy Chief Financial Officer
--
--
Mr. Johnathan Lin
Mr. Johnathan Lin
Chief Operating Officer, Human Resource Manager
Chief Operating Officer, Human Resource Manager
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jian Hua
Dr. Jian Hua
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lina Song
Ms. Lina Song
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Ms. Fei Xu
Ms. Fei Xu
General Manager, Director
General Manager, Director
--
--
Mr. Joel Adalberto Gallo
Mr. Joel Adalberto Gallo
Independent Director
Independent Director
--
--
Mr. Douglas Bruce Noyes
Mr. Douglas Bruce Noyes
Independent Director
Independent Director
--
--
Dr. James Jiayuan Tong
Dr. James Jiayuan Tong
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2024Q3
FY2023
FY2023Q4
FY2023Q3
FY2022
业务USD
名称
营收
占比
Cannabis E-vapors
5.92M
80.33%
Medical nebulizers
650.69K
8.83%
Candy sales online
570.89K
7.75%
Consuming E-vapors
185.30K
2.51%
Others
30.98K
0.42%
其他
11.11K
0.15%
地区USD
名称
营收
占比
North America
6.44M
87.40%
Europe
618.62K
8.40%
Other
309.43K
4.20%
业务
地区
业务USD
名称
营收
占比
Cannabis E-vapors
5.92M
80.33%
Medical nebulizers
650.69K
8.83%
Candy sales online
570.89K
7.75%
Consuming E-vapors
185.30K
2.51%
Others
30.98K
0.42%
其他
11.11K
0.15%

股东统计

持股股东
股东类型
持股股东
持股股东
占比
其他
100.00%
持股股东
持股股东
占比
其他
100.00%
股东类型
持股股东
占比
其他
100.00%

机构持股

由于公司未披露,未能获取相关数据
报告期
机构数
持股数
持股占比
持股变动
暂无数据

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
暂无数据

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI